EGFR and gastric cancer: For example, METTL3-mediated m6A modification destabilizes SOCS2 mRNA in HCC and BATF2 mRNA in gastric cancer [32] and promotes the translation of epidermal growth factor receptor (EGFR) and the Hippo pathway effector TAZ in human lung cancer cells [33].